C. Boyden Gray is listed as a director on 9 SEC Form D filings by 1 issuer between Oct 2009 and Jun 2015: Altor Bioscience Corp (Miramar, FL — biotechnology — 2009–2015; $30.3M reported sold to 29 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Fred Middleton (9 shared filings), Hing C. Wong (9 shared filings), Peter Rhode (9 shared filings), Bee-Yau Huang (6 shared filings), Adam Waldman, J.D. (5 shared filings) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around C.. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for C. Boyden Gray and found 9 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.